Bile Acids, Fractionated and Total, Serum
Measurement of tauro- and glycol-conjugated and unconjugated bile acid constituents in serum
Monitoring patients receiving bile acid therapy, such as cholic acid, deoxycholic acid, or ursodeoxycholic acid
Aiding in the evaluation of liver function; evaluation of liver function changes before the formation of more advanced clinical signs of illness such as icterus
Determining hepatic dysfunction as a result of chemical and environmental injury
Indication of hepatic histological improvement in chronic hepatitis C patients responding to interferon treatment
Indication of intrahepatic cholestasis of pregnancy
Bile acids are elevated in individuals with liver dysfunction.
Fractionated bile acids, including tauro- and glycol-conjugates of cholic acid, chenodeoxycholic acid, deoxycholic acid, and ursodeoxycholic acid are individually summed and reported.
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Bile Acids, Fractionated and Tot, S